Standout Papers

Real-World Evidence — What Is It and What Can It Tell Us? 2016 2026 2019 2022 1.3k
  1. Real-World Evidence — What Is It and What Can It Tell Us? (2016)
    Rachel E. Sherman, Steven A. Anderson et al. New England Journal of Medicine
  2. Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy (2024)
    Nicole Verdun, Peter Marks New England Journal of Medicine

Immediate Impact

8 by Nobel laureates 31 from Science/Nature 69 standout
Sub-graph 1 of 22

Citing Papers

T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2025 Standout
Causal machine learning for predicting treatment outcomes
2024 Standout

Works of Peter Marks being referenced

Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
2024 Standout
Real-World Evidence — What Is It and What Can It Tell Us?
2016 Standout

Author Peers

Author Last Decade Papers Cites
Peter Marks 1499 506 445 743 622 101 4.8k
Jeffrey A. Kant 1467 247 282 839 778 82 4.4k
Robert A. Swerlick 1885 634 420 806 489 134 5.9k
Dan L. Longo 875 697 582 1290 836 75 4.8k
Mirjam G.A. oude Egbrink 1357 582 126 833 447 100 5.1k
Bernhard H. Rauch 1691 497 189 317 367 156 4.4k
E.H. Cooper 1220 485 320 1084 248 145 4.1k
Tsz‐Kwong Man 1537 406 462 895 371 124 3.8k
Wouter W. van Solinge 2434 895 544 527 1039 189 6.1k
Shu‐Cheng Chen 1043 232 144 807 357 124 6.7k
Knut Liestøl 1766 162 263 757 626 190 6.4k

All Works

Loading papers...

Rankless by CCL
2026